2013
DOI: 10.1136/gutjnl-2012-303635
|View full text |Cite
|
Sign up to set email alerts
|

Autoimmune pancreatitis in MRL/Mp mice is a T cell-mediated disease responsive to cyclosporine A and rapamycin treatment

Abstract: The calcineurin inhibitor cyclosporine A and the mammalian target of rapamycin (mTOR) inhibitor, rapamycin, improve the course of AIP in MRL/Mp mice via different mechanisms. These findings further support the concept of autoreactive T cells as key players in the pathogenesis of AIP and suggest that cyclosporine A and rapamycin should be considered for treatment of AIP in humans.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

7
71
0
1

Year Published

2014
2014
2018
2018

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 61 publications
(79 citation statements)
references
References 64 publications
7
71
0
1
Order By: Relevance
“…Consistent with previous reports (27,31), MRL/Mp mice treated with poly (I:C) exhibited several important histological features of pancreatitis that were similar to human AIP. Thus, after treatment with poly (I:C), the pancreatic tissue of MRL/Mp mice exhibited a massive infiltration of immune cells, destruction of the pancreatic acinar architecture, and pancreatic fibrosis (Fig.…”
Section: Resultssupporting
confidence: 79%
See 2 more Smart Citations
“…Consistent with previous reports (27,31), MRL/Mp mice treated with poly (I:C) exhibited several important histological features of pancreatitis that were similar to human AIP. Thus, after treatment with poly (I:C), the pancreatic tissue of MRL/Mp mice exhibited a massive infiltration of immune cells, destruction of the pancreatic acinar architecture, and pancreatic fibrosis (Fig.…”
Section: Resultssupporting
confidence: 79%
“…In our initial studies, we used a well-established animal model of human AIP to identify the type of immune cells and cytokines that might be involved in the development of human AIP (27,31). Consistent with previous reports (27,31), MRL/Mp mice treated with poly (I:C) exhibited several important histological features of pancreatitis that were similar to human AIP.…”
Section: Resultssupporting
confidence: 61%
See 1 more Smart Citation
“…Recently, Schwaiger et al published a study using a murine model showing that an alternative immunomodulatory agent may be more effi cacious than azathioprine [ 9 ]. They developed a model in MRL/Mp female mice that when exposed to polyinosinic:polycytidylic acid induces an infl ammatory condition that mimics the histologic and phenotypic features of human type 1 AIP.…”
Section: Future Studiesmentioning
confidence: 97%
“…Therefore, interventions targeting the armory of disease-causing inflammatory cells and molecules have been proposed and tested. As listed in Table 1, non-specific interventions that are routinely used include depletion of cell populations by cyclophosphamide, 18 depletion of cell subset by antibodies(anti-CD3 mAb for T cell depletion 29 or anti-CD20 mAb for B cell depletion 30,31 ]), depletion of inflammatory cytokines by antibody, 32,33 universal tolerance induction by immunosuppressant drugs (dexamethasone, FK506, rapamycin or cyclosporin A), [34][35][36] entrapment of all leukocyte into lymph nodes away from inflammatory tissues (FTY720), 37,38 etc. As already pointed out above, these approaches run into the risk of increasing the chance of infection and tumorigenesis (Fig.…”
Section: Taming Inflammationmentioning
confidence: 99%